621 related articles for article (PubMed ID: 17662044)
1. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.
Montoya CJ; Pollard D; Martinson J; Kumari K; Wasserfall C; Mulder CB; Rugeles MT; Atkinson MA; Landay AL; Wilson SB
Immunology; 2007 Sep; 122(1):1-14. PubMed ID: 17662044
[TBL] [Abstract][Full Text] [Related]
2. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
3. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.
Exley MA; Hou R; Shaulov A; Tonti E; Dellabona P; Casorati G; Akbari O; Akman HO; Greenfield EA; Gumperz JE; Boyson JE; Balk SP; Wilson SB
Eur J Immunol; 2008 Jun; 38(6):1756-66. PubMed ID: 18493987
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 6B11 mAb and α-GalCer-loaded CD1d dextramers for detection of iNKT cells by flow cytometry.
Lenart M; Gruca A; Mueck A; Rutkowska-Zapała M; Surman M; Szaflarska A; Kobylarz K; Baran J; Siedlar M
J Immunol Methods; 2017 Jul; 446():1-6. PubMed ID: 28365328
[TBL] [Abstract][Full Text] [Related]
5. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
[TBL] [Abstract][Full Text] [Related]
6. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
Singh AK; Shukla NK; Das SN
Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
[TBL] [Abstract][Full Text] [Related]
7. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.
Kis J; Engelmann P; Farkas K; Richman G; Eck S; Lolley J; Jalahej H; Borowiec M; Kent SC; Treszl A; Orban T
J Leukoc Biol; 2007 Mar; 81(3):654-62. PubMed ID: 17151140
[TBL] [Abstract][Full Text] [Related]
8. Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.
O'Reilly V; Zeng SG; Bricard G; Atzberger A; Hogan AE; Jackson J; Feighery C; Porcelli SA; Doherty DG
PLoS One; 2011; 6(12):e28648. PubMed ID: 22174854
[TBL] [Abstract][Full Text] [Related]
9. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site.
Nakamura T; Sonoda KH; Faunce DE; Gumperz J; Yamamura T; Miyake S; Stein-Streilein J
J Immunol; 2003 Aug; 171(3):1266-71. PubMed ID: 12874214
[TBL] [Abstract][Full Text] [Related]
10. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
11. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
13. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
14. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
Yang G; Artiaga BL; Lewis ST; Driver JP
Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
[TBL] [Abstract][Full Text] [Related]
15. Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.
Snyder-Cappione JE; Nixon DF; Chi JC; Nguyen ML; Kirby CK; Milush JM; Koth LL
Eur J Immunol; 2013 Aug; 43(8):2194-205. PubMed ID: 23661497
[TBL] [Abstract][Full Text] [Related]
16. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
17. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
Thedrez A; de Lalla C; Allain S; Zaccagnino L; Sidobre S; Garavaglia C; Borsellino G; Dellabona P; Bonneville M; Scotet E; Casorati G
Blood; 2007 Jul; 110(1):251-8. PubMed ID: 17363727
[TBL] [Abstract][Full Text] [Related]
18. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
De Biasi S; Bianchini E; Nasi M; Digaetano M; Gibellini L; Carnevale G; Borghi V; Guaraldi G; Pinti M; Mussini C; Cossarizza A
AIDS; 2016 Nov; 30(17):2599-2610. PubMed ID: 27782963
[TBL] [Abstract][Full Text] [Related]
20. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D; Mi QS; Hussain S; Delovitch TL
J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
